MOSCOW, Feb 9 – RIA Novosti. The supply of the Russian Sputnik V coronavirus vaccine may begin no earlier than May-June, only after the completion of the bulk of the mass vaccination in Russia, said Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF).
“Large-scale deliveries to the European Union are possible only after the large-scale vaccination of Russians is completed. That is, only after everyone in Russia who wanted to be vaccinated will be vaccinated,” Dmitriev said on the Russia 24 TV channel.
Your browser does not support this video format.
“Only then can we ensure really large-scale supplies to the EU, that is, we are talking about May-June this year, not earlier,” he stressed.
Earlier, the developers of the vaccine on a Twitter account reported that RDIF could supply 100 million doses of Sputnik V to the EU in the second quarter of 2021 after the completion of the bulk of the mass vaccination in Russia.
RDIF filed an application for registration of the Sputnik V vaccine with the European Medicines Agency (EMA) on January 29 and has confirmed that the application was accepted. The rate of approval of the application is determined by the EMA, specified in the RDIF.
If a conditional marketing authorization is issued and approved by the European Commission, the Russian vaccine can be centrally supplied to the EU. The European Union, even before the appearance of the first approved vaccines against coronavirus, made a decision on their centralized procurement. In total, contracts were signed with six manufacturers.
Earlier, German Chancellor Angela Merkel said that she had offered Russian President Vladimir Putin assistance in registering the Sputnik V vaccine in the European Union, she stressed that the use of the drug in the country is possible only after approval by the European Medicines Agency. At the same time, the member state of the union Hungary independently purchases the vaccine in the Russian Federation, the same approach is now being discussed in the Czech Republic.